Related Experiment Videos
Drug Trials Snapshots and Sexless Drug Labels
G Elliott Cook1, Erin E Wilhelm2
1Provider Resources, Inc, Erie, Pennsylvania.
JAMA Internal Medicine
|December 6, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials.
Therapeutic innovation & regulatory science·2020
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.
Journal of diabetes and its complications·2017
Data sharing for public health research: A qualitative study of industry and academia.
Communication & medicine·2015
Advancing a Vision for Regulatory Science Training.
Clinical and translational science·2015
Serologic Immunity to Hepatitis A and B in US Adults and High-Risk Populations.
JAMA internal medicine·2026
Management of Shoulder Pain in Primary Care: A Review.
JAMA internal medicine·2026
Medicare Advantage and Type 2 Diabetes Outcomes.
JAMA internal medicine·2026
Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review.
JAMA internal medicine·2026
Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.
Research in social & administrative pharmacy : RSAP·2026
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026